Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users
- 1 December 2000
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (18) , 2823-2829
- https://doi.org/10.1097/00002030-200012220-00003
Abstract
To identify subsets of CD4 T lymphocytes that can predict the development of AIDS and to assess whether increased levels of these cellular markers could provide additional independent prognostic information to the CD4 T cell count and plasma HIV-1-RNA levels. In a prospective study, a cohort of 85 HIV-positive intravenous drug users [clinical categories of the CDC classification A (n = 48) and B (n = 37)] were followed for a period of 37+/-13 months. Memory and activated CD4 and CD8 T cells were quantitated by three-colour flow cytometry at baseline and expressed as a percentage of total CD4 and CD8 lymphocytes. Clinical evaluations were performed at 6 month intervals. The relationships between these lymphocyte subsets and progression to AIDS were studied using Kaplan-Meier plots and proportional hazards regression models. After adjustment for the level of CD4 T cells and plasma HIV-1-RNA levels, the elevation in the subset CD4+CD38+DR+ was the marker within the functionally distinct subsets of CD4 T lymphocytes with additional prognostic value in bivariate Cox regression models. In multivariate models, increased percentages of CD4+CD38+DR+ T cells provided the strongest independent prognostic information for progression to AIDS (relative hazard, 1.07; P < 0.0001). Our results suggest that high levels of CD4+CD38+HLA-DR+ T cells reflect the increasing degree of CD4 T cell activation during the progression of HIV infection, and could be used together with the CD4 T cell and HIV-RNA levels to evaluate more accurately the progressive cellular immune impairment associated with the risk of progression to AIDS.Keywords
This publication has 38 references indexed in Scilit:
- The Prognostic Significance in HIV Infection of Immune Activation Represented by Cell Surface Antigen and Plasma Activation Marker ChangesClinical Immunology, 1999
- Changes in CD4+and CD8+T Cell Subsets in Response to Highly Active Antiretroviral Therapy in HIV Type 1-Infected Patients with Prior Protease Inhibitor ExperienceAIDS Research and Human Retroviruses, 1998
- Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of deathAIDS, 1997
- During HIV Infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose Vβ repertoire is similar to that of CD4+ CD38− T-cells+Clinical Immunology and Immunopathology, 1995
- CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-upAIDS, 1993
- The Impaired in Vitro Production of Interleukin-2 in HIV Infection Is Negatively Correlated to the Number of Circulating CD4+ DR+ T Cells and Is Reversed by Allowing T Cells to Rest in Culture: Arguments for in Vivo CD4+ T Cell ActivationClinical Immunology and Immunopathology, 1993
- Immune changes in HIV-1 infection: Significant correlations and differences in serum markers and lymphoid phenotypic antigensClinical Immunology and Immunopathology, 1992
- Quantitative changes in t helper inducer (cd4+ cd45ra−), t suppressor inducer (cd4+ cd45ra+), t suppressor (cd8+ cd11b+), and t cytotoxic (cd8+ cd11b−) subsets in human immunodeficiency virus infectionJournal of Clinical Laboratory Analysis, 1991
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958